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Clopidogrel hydrogen sulfate (ClopH+•HSO4
-) is a potent platelet anti-
aggregation drug acting as a selective and irreversible inhibitor of 
ADP-induced platelet aggregation, or more specifically a 
thienopyridine class inhibitor of the P2Y12 ADP platelet receptors 
found on the membranes of platelet cells. Chemically is a (S)-(+)-
methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-
yl)acetate hydrogen sulfate. Clopidogrel hydrochloride is another salt 
form of clopidogrel that is available in its generic pharmaceutical 
formulations.      
The clopidogrel molecule exists in two enantiomeric forms, the R(−) 
and S(+) isomers, out of which the dextrorotatory one is more active 
and better tolerated in pharmaceutical use.[1] The S(+)clopidogrel 
hydrogen sulfate salt is commercialized as PLAVIX® by Sanofi and 
Bristol-Myers Squibb, as well as under several generic brand names, 
and is one of the top-selling drugs in the word . Some different 
polymorphic and pseudo-polymorphic forms of this drug are known, 
however, only polymorphs I and II are used in pharmaceutical 
formulations.[2] X-ray crystal structures for both polymorphs, the 
monoclinic form I [3] and the orthorhombic form II [4], have been 
previously reported (CSD refcodes FUQMOU01 and FUQMOU). 
Because only another structure of S(+)clopidogrel salt is known so far, 
the S(+)clopidogrel isopropylsulfate (refcode YEXHOZ) [5], a 
systematic co-crystallization screening for molecular salts of 
clopidogrel with strong organic acids has been performed, in order to 
obtain new salts of this important drug.  
Compounds Studied 
The systematic analysis of the molecular geometries and crystal packing, 
and the study of the thermodynamic properties are expected to Structure-
Properties Relationships for the aforementioned salts of clopidogrel. 
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Single yellow crystals of PCC were obtained by slow 
evaporation of the solvent: 
Characterization of PCC  
Structure determination was performed by Single 
Crystal X-Ray Diffraction Analysis confirming the 
structure 1 and structure 2 to be molecular salt forms 
of New Chemical Entity (NEC) not so far deposited in 
the Cambridge Structure Database CCDC. 
Work in Progress 
pKa: 0.36 (NIST) 
Salt formation:  
Medium-strong H-bonded (+N-H···O-) 
ionic couples [6-9] 
 
ΔpKa  =  pKa(D−H) – pKa(A−H
+) = -4.26 
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Discrete S(+)ClopH+•Pic- ionic couple 
C16H17ClNO2S)
+•(C6H2N3O7)
-•C2H6O  
 2 independent S(+)ClopH+•Pic- ionic couples A & B 
(C16H17ClNO2S)
+•(C6H2N3O7)
- 
Couple A Couple B 
Structure 1 CDCC (1448941) 
Structure 2 (CDCC 1448942) 
S(+)Clop (free base): 
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polymorph II 
pKa: 4.62 (est.) 
